IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $505,991 | +10.6% | 11,155 | 0.0% | 0.03% | +8.0% |
| Q2 2023 | $457,690 | +14.8% | 11,155 | -0.0% | 0.02% | +13.6% |
| Q1 2023 | $398,751 | -5.8% | 11,157 | -0.5% | 0.02% | -12.0% |
| Q4 2022 | $423,477 | -15.0% | 11,212 | -0.4% | 0.02% | -24.2% |
| Q3 2022 | $498,000 | +19.7% | 11,255 | +0.2% | 0.03% | +26.9% |
| Q2 2022 | $416,000 | +0.2% | 11,235 | +0.2% | 0.03% | -3.7% |
| Q1 2022 | $415,000 | +21.0% | 11,212 | -0.5% | 0.03% | +22.7% |
| Q4 2021 | $343,000 | -8.0% | 11,274 | +1.3% | 0.02% | -15.4% |
| Q3 2021 | $373,000 | -16.0% | 11,134 | +0.1% | 0.03% | -25.7% |
| Q2 2021 | $444,000 | -11.0% | 11,120 | +0.2% | 0.04% | -68.2% |
| Q1 2021 | $499,000 | -20.5% | 11,100 | 0.0% | 0.11% | -29.0% |
| Q4 2020 | $628,000 | +18.9% | 11,100 | -0.2% | 0.16% | -3.1% |
| Q3 2020 | $528,000 | – | 11,120 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |